BECN1 and pulmonary fibrosis: miR-1224-5p could directly inhibit the expression of the target gene beclin 1 (BECN1), which in turn blocked the translocation of Parkinson’s disease protein 2 (PARK2) to mitochondria, resulting in mitochondrial damage and promoting pulmonary fibrosis [61].